Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Sep;64(3):419–421. doi: 10.1038/bjc.1991.324

The current status of scientific research and hormonal treatments for carcinoma of the prostate.

J Waxman, A Saini
PMCID: PMC1977666  PMID: 1911179

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackard C. E., Byar D. P., Jordan W. P., Jr Orchiectomy for advanced prostatic carcinoma. A reevaluation. Urology. 1973 Jun;1(6):553–560. doi: 10.1016/0090-4295(73)90515-3. [DOI] [PubMed] [Google Scholar]
  2. Bookstein R., Shew J. Y., Chen P. L., Scully P., Lee W. H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science. 1990 Feb 9;247(4943):712–715. doi: 10.1126/science.2300823. [DOI] [PubMed] [Google Scholar]
  3. Carter B. S., Epstein J. I., Isaacs W. B. ras gene mutations in human prostate cancer. Cancer Res. 1990 Nov 1;50(21):6830–6832. [PubMed] [Google Scholar]
  4. Crawford E. D., Eisenberger M. A., McLeod D. G., Spaulding J. T., Benson R., Dorr F. A., Blumenstein B. A., Davis M. A., Goodman P. J. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med. 1989 Aug 17;321(7):419–424. doi: 10.1056/NEJM198908173210702. [DOI] [PubMed] [Google Scholar]
  5. Fleming W. H., Hamel A., MacDonald R., Ramsey E., Pettigrew N. M., Johnston B., Dodd J. G., Matusik R. J. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res. 1986 Mar;46(3):1535–1538. [PubMed] [Google Scholar]
  6. Fowler J. E., Jr, Lau J. L., Ghosh L., Mills S. E., Mounzer A. Epidermal growth factor and prostatic carcinoma: an immunohistochemical study. J Urol. 1988 Apr;139(4):857–861. doi: 10.1016/s0022-5347(17)42662-0. [DOI] [PubMed] [Google Scholar]
  7. Labrie F., Dupont A., Giguere M., Borsanyi J. P., Lacourciere Y., Belanger A., Lachance R., Emond J., Monfette G. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients. J Steroid Biochem. 1987;27(1-3):525–532. doi: 10.1016/0022-4731(87)90350-5. [DOI] [PubMed] [Google Scholar]
  8. MacDonald A., Chisholm G. D., Habib F. K. Production and response of a human prostatic cancer line to transforming growth factor-like molecules. Br J Cancer. 1990 Oct;62(4):579–584. doi: 10.1038/bjc.1990.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Morris G. L., Dodd J. G. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol. 1990 Jun;143(6):1272–1274. doi: 10.1016/s0022-5347(17)40253-9. [DOI] [PubMed] [Google Scholar]
  10. NESBIT R. M., BAUM W. C. Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. J Am Med Assoc. 1950 Aug 12;143(15):1317–1320. doi: 10.1001/jama.1950.02910500019005. [DOI] [PubMed] [Google Scholar]
  11. Osborne C. K., Blumenstein B., Crawford E. D., Coltman C. A., Jr, Smith A. Y., Lambuth B. W., Chapman R. A. Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study. J Clin Oncol. 1990 Oct;8(10):1675–1682. doi: 10.1200/JCO.1990.8.10.1675. [DOI] [PubMed] [Google Scholar]
  12. Pavone-Macaluso M., de Voogt H. J., Viggiano G., Barasolo E., Lardennois B., de Pauw M., Sylvester R. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group. J Urol. 1986 Sep;136(3):624–631. doi: 10.1016/s0022-5347(17)44996-2. [DOI] [PubMed] [Google Scholar]
  13. Plowman P. N., Perry L. A., Chard T. Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer. Br J Urol. 1987 Mar;59(3):255–257. doi: 10.1111/j.1464-410x.1987.tb04617.x. [DOI] [PubMed] [Google Scholar]
  14. Qayum A., Gullick W., Clayton R. C., Sikora K., Waxman J. The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors. Br J Cancer. 1990 Jul;62(1):96–99. doi: 10.1038/bjc.1990.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rijnders A. W., van der Korput J. A., van Steenbrugge G. J., Romijn J. C., Trapman J. Expression of cellular oncogenes in human prostatic carcinoma cell lines. Biochem Biophys Res Commun. 1985 Oct 30;132(2):548–554. doi: 10.1016/0006-291x(85)91168-4. [DOI] [PubMed] [Google Scholar]
  16. Sogani P. C., Ray B., Whitmore W. F., Jr Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment. Urology. 1975 Aug;6(2):164–166. doi: 10.1016/0090-4295(75)90704-9. [DOI] [PubMed] [Google Scholar]
  17. Trachtenberg J., Walsh P. C. Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. J Urol. 1982 Mar;127(3):466–471. doi: 10.1016/s0022-5347(17)53868-9. [DOI] [PubMed] [Google Scholar]
  18. Treiger B., Isaacs J. Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J Urol. 1988 Dec;140(6):1580–1586. doi: 10.1016/s0022-5347(17)42131-8. [DOI] [PubMed] [Google Scholar]
  19. Viola M. V., Fromowitz F., Oravez S., Deb S., Finkel G., Lundy J., Hand P., Thor A., Schlom J. Expression of ras oncogene p21 in prostate cancer. N Engl J Med. 1986 Jan 16;314(3):133–137. doi: 10.1056/NEJM198601163140301. [DOI] [PubMed] [Google Scholar]
  20. Waxman J. Gonadotrophin hormone releasing analogues open new doors in cancer treatment. Br Med J (Clin Res Ed) 1987 Oct 31;295(6606):1084–1085. doi: 10.1136/bmj.295.6606.1084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Waxman J., Sandow J., Abel P., Barton C., Keane P., Williams G. Three-monthly GnRH agonist (buserelin) for prostatic cancer. Br J Urol. 1990 Jan;65(1):43–45. doi: 10.1111/j.1464-410x.1990.tb14659.x. [DOI] [PubMed] [Google Scholar]
  22. White J. W. II. The Present Position of the Surgery of the Hypertrophied Prostate. Ann Surg. 1893 Aug;18(2):152–188. doi: 10.1097/00000658-189307000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES